In general, we apply the following conditions to each of our corporate partnerships:
Where appropriate, Mind will provide recognition of corporate support in a communications plan agreed between both parties, and Mind's key corporate partners will be disclosed in financial reporting.
Mind will not accept support that could compromise who we are and what we do - or undermine our effectiveness in achieving our goals. Mind’s corporate partnerships team follow a due diligence process, to ensure any potential relationship is in accordance with our ethical policy and principles. Where there is a potential concern area, the opportunity will be escalated to Mind’s Ethical Committee for a final decision.
Circumstances where there may be legitimate concern include - but are not limited to:
Opportunities to work with companies from the above list will be reviewed on a case by case basis, and a decision to pursue/ not pursue will be reached on balance of the nature of the proposed relationship and what is in the best interest of our organisation and beneficiaries.
Mind’s ethical fundraising and investment policy states that we will not accept donations from or hold shares in companies manufacturing pharmaceuticals, lest this should compromise our position on the uses of medication. This policy and any future policy decision of this kind will be considered only after full consultation with Mind's key stakeholders.
We are committed to retaining our independent stance in relation to the use of medication so that we can continue providing a voice for people with experience of mental health problems. This policy is also binding on all local Minds, as provided for in their affiliation agreement.
Staff at Mind and local Minds may not accept sponsorship or donations from pharmaceutical companies for their own events. Staff may attend conferences, seminars or other events run by other organisations that are sponsored by pharmaceutical companies provided they do not directly benefit financially from such attendance. This would prohibit the acceptance of fees and expenses to participate in such events.
Mind staff will not normally speak at events sponsored by pharmaceutical companies. However, the Chief Executive will review specific requests and may give dispensation to speak.
The definition of pharmaceutical manufacturers does not extend to retailers such as chemists who predominantly manufacture own brand over the counter medication, unless they are significant manufacturers of pharmaceuticals associated with the treatment of mental health problems.
Companies who produce alternative remedies, e.g. St John's Wort, vitamins, etc, are also excluded from this policy.
Individuals who work for a pharmaceutical company will not be excluded from donating or taking part in Mind events as this would result in unfairly penalising individuals on the basis of where they work. However, they will be precluded from entering into match-funding arrangements with their organisation, as Mind will not accept match-funds from pharmaceutical manufacturers.
Mind wants their mental health training and support to be available to and benefit everyone, regardless of their employer or industry. Mind’s mental health training and consultancy and Workplace Wellbeing Index, is available to companies manufacturing pharmaceuticals.